<DOC>
	<DOCNO>NCT00965055</DOCNO>
	<brief_summary>Response statin therapy elevate low density lipoprotein variable may influence cholesterol absorption . This study evaluate whether combination therapy atorvastatin/ezetimibe superior atorvastatin alone subject less 25 % LDL reduction start dose statin ( eg , atorvastatin 10 mg daily simvastatin 20 mg daily ) .</brief_summary>
	<brief_title>Ezetimibe Patients Hypo-responsive Statins</brief_title>
	<detailed_description>Specific Aim 1 To identify patient population see University California , San Diego general internal medicine cardiology subspecialty clinic well referral community physician hyporesponsive statin therapy ( defined initial LDL reduction &lt; 25 % response 10mg atorvastatin 20mg simvastatin- expect mean reduction 35 % -37 % start dose simvastatin atorvastatin ) . Specific Aim 2 To test hypothesis , prospective study , hyporesponse statin therapy may relate increase cholesterol absorption , hyporesponse may overcome addition ezetimibe , specific cholesterol absorption inhibitor . Specific Aim 3 To evaluate whether patient le 25 % LDL reduction 10 mg atorvastatin ( 20 mg simvastatin ) would achieve significantly great LDL reduction combination therapy ( atorvastatin/ezetimibe ) statin dose titration ( use atorvastatin ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Patients need LDLC level 130 mg/dl great without treatment . They must demonstrate initial LDLC reduction le 25 % 10 mg atorvastatin 20 mg simvastatin . Eligible patient deem physician eligible lipid lower therapy statin stable CAD , CAD equivalent per NCEP guideline , Framingham risk 1020 % . Recent ( &lt; 3 month ) diagnosis Acute Coronary Syndromes due ethical consideration [ 10 ] . Pregnant patient , plan become pregnant , breast feeding , liver disease , history allergic reaction agent use trial , history myositis , myopathy , pancreatitis , hypertriglyceridemia ( TG &gt; 400 mg/dL ) , history significant alcohol drug abuse , history organ transplantation , patient refusal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>